JustChartThings

PIRS on the way to recovery?

Long
NASDAQ:PIRS   Pieris Pharmaceuticals, Inc.
First close above the EMA10 in 20 trading days, when stocks began tumbling in January. In at 1.57 last week, looking for a continuation closing above the EMA10 on Monday. Recent MACD cross and OBV increase support the continuation; RSI cross above 50 and we may see a return to the MA50 in the near term. PIRS seems like a good long-term value play here, but taking profits at appropriate times seems like the best thing to do in the current market unless you have a lot of flexibility.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.